Please use this identifier to cite or link to this item:
http://dx.doi.org/10.25673/108835
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Abobarin-Adeagbo, Abimbola | - |
dc.contributor.author | Wienke, Andreas | - |
dc.contributor.author | Girndt, Matthias | - |
dc.contributor.author | Pliquett, Rainer U. | - |
dc.date.accessioned | 2023-07-05T12:19:40Z | - |
dc.date.available | 2023-07-05T12:19:40Z | - |
dc.date.issued | 2020 | - |
dc.identifier.uri | https://opendata.uni-halle.de//handle/1981185920/110790 | - |
dc.identifier.uri | http://dx.doi.org/10.25673/108835 | - |
dc.description.abstract | Background: Aim of this study is to investigate a possible association of hypoglycemic episodes and arterial hypertension. We hypothesize that hospitalized insulin-treated diabetes patients with hypertensive crisis have more hypoglycemic episodes than their counterparts without hypertensive crisis on admission. Methods: In a prospective, observational cohort study, 65 insulin-treated diabetes patients (type 1, type 2, type 3c) were included in Group 1, when a hypertensive crisis was present, as control patients in Group 2 without hypertensive crisis or hypoglycemia, in Group 3, when a symptomatic hypoglycemia was present on admission. All patients were subjected to open-label continuous glucose monitoring, 24-h blood-pressure- and Holter electrocardiogram recordings, and to laboratory tests including plasma catecholamines. Results: 53 patients, thereof 19 Group-1, 19 Group-2, 15 Group-3 patients, completed this study. Group-1 patients had the highest maximum systolic blood pressure, a higher daily cumulative insulin dose at admission, a higher body-mass index, and a higher plasma norepinephrine than control patients of Group 2. Group-3 patients had more documented hypoglycemic episodes (0.8 ± 0.5 per 24 h) than Group-2 patients (0.2 ± 0.3 per 24 h), however, they were not different to the ones in Group-1 patients (0.4 ± 0.4 per 24 h). Plasma norepinephrine and mean arterial blood pressure were higher Group-1 and Group-3 patients than in control patients of Group 2. At discharge, the daily cumulative insulin dose was reduced in Group-1 (− 18.4 ± 24.9 units) and in Group-3 patients (− 18.6 ± 22.7 units), but remained unchanged in Group-2 control patients (− 2.9 ± 15.6 units). Conclusions: An association between hypoglycemic events and uncontrolled hypertension was found in this study. | eng |
dc.language.iso | eng | - |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
dc.subject.ddc | 610 | - |
dc.title | Glycopenia - induced sympathoadrenal activation in diabetes mellitus and uncontrolled arterial hypertension : an observational study | eng |
dc.type | Article | - |
local.versionType | publishedVersion | - |
local.bibliographicCitation.journaltitle | Diabetology & metabolic syndrome | - |
local.bibliographicCitation.volume | 12 | - |
local.bibliographicCitation.publishername | BioMed Central | - |
local.bibliographicCitation.publisherplace | London | - |
local.bibliographicCitation.doi | 10.1186/s13098-020-00613-4 | - |
local.subject.keywords | Arterial hypertension, norepinephrine, hypoglycemia, diabetes mellitus | - |
local.openaccess | true | - |
dc.identifier.ppn | 1755150539 | - |
local.bibliographicCitation.year | 2020 | - |
cbs.sru.importDate | 2023-07-05T12:18:49Z | - |
local.bibliographicCitation | Enthalten in Diabetology & metabolic syndrome - London : BioMed Central, 2009 | - |
local.accessrights.dnb | free | - |
Appears in Collections: | Open Access Publikationen der MLU |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
s13098-020-00613-4.pdf | 1.1 MB | Adobe PDF | ![]() View/Open |